SecBot SecBot
8-K ·Filed Oct 1, 2026

FBIO

Fortress Biotech, Inc.
BULLISH
Impact 5/10
Horizonweeks Processed26d 5h ago SEC0001104659-26-112845
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

With the Oaktree facility fully repaid and terminated, Fortress Biotech has eliminated a significant debt burden. Monitor upcoming quarterly filings for cash runway and any new financing plans, as the company may still need capital for operations.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+5d
FBIO ▲ +5.17% at T+5d
LONG call ✓ call won +5.17% · α vs SPY +4.01% · entry $2.03 → $2.14
Next anchor: T+20d tomorrow
Latest observation: T+15 +6.91% FF3 residual α
Entry = T+0 close
Oct 1, 2026
via day close
T+1d
+2.96%
call +2.96% · α +2.28%
$2.09
settled 26d ago
T+5d
+5.17%
call +5.17% · α +4.01%
$2.14
settled 20d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Fortress Biotech repaid the remaining $15.0 million in outstanding principal under its Oaktree senior secured credit facility on September 30, 2026, along with approximately $435,000 in accrued interest, a $150,000 prepayment fee, and other closing costs. All liens and security interests were released, and the credit agreement was terminated.

Key Facts

  • Repaid remaining $15.0 million in principal under the Oaktree senior secured credit facility on September 30, 2026.
  • Paid approximately $435,000 in accrued interest, a $150,000 prepayment fee, and other closing costs.
  • All liens and security interests on company property were released and terminated.
  • The Oaktree Agreement automatically terminated upon repayment.
  • Original facility was $50.0 million, entered July 25, 2024, and amended twice (Dec 12, 2025 and Feb 22, 2026).

Financial Impact

Debt elimination of $15.0 million plus $585,000 in fees and accrued interest; total cash outlay approximately $15.585 million.

debtinterest expenseleverage

Risk Factors

  • Cash used for repayment reduces liquidity; the company may need to raise additional capital.
  • No new financing or operational catalyst disclosed alongside the debt repayment.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-112845
Document: 0001104659-26-112845-index-headers.html0001104659-26-112845
Document: 0001104659-26-112845-index.html0001104659-26-112845
Document: 0001104659-26-112845.txt0001104659-26-112845
4 reports for FBIO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FBIO — sortable, filterable
TypeNow
Oct 1, 2026
26d ago
8-K
BULLISH ★ 5/10
$2.03 $2.14▲ +5.17%▲ +4.01%$1.93 (−4.93%)
May 18, 2026
23w ago
Press Release
NEUTRAL ★ 2/10
$2.48 $2.69▲ +8.47%▲ +6.85%$1.93 (−22.18%)
May 4, 2026
25w ago
Press Release
NEUTRAL ★ 2/10
$2.38 $2.24▼ −5.88%▼ −8.82%$1.93 (−18.91%)
Mar 30, 2026
30w ago
Press Release
BULLISH ★ 8/10
$2.79 $2.31▼ −17.20%▼ −21.15%$1.93 (−30.82%)
Showing 4 of 4

US Market Status

Market Closed — Opens Thu (11h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 1, 2026